As I said; you are clearly bothered by contact details in signatures.
Why?
Will removal of contact details make NOR a better stock?
Back on topic; the Q today was woeful and laughable. Repeated sentences; $50k in the bank; continuation of the same carrot dangling; a declining business which really should be taken behind the shed and put out of its misery.
Avicena looks promising though... opportunistic of course. A pivot from mineral assays to Covid. Wow. How?
All imo
Ann: Quarterly Activities and Appendix 4C Cashflow Report, page-56
Add NOR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.56M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 160000 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 1440 | 1 |
View Market Depth
| Last trade - 16.12pm 02/10/2024 (20 minute delay) ? |
| NOR (ASX) Chart |
Day chart unavailable